| |
Atrial fibrillation
|
No atrial fibriallation
|
Chi-square/df/p or t/d.f/p
|
|---|
|
Gender (male/female)
|
34 (31.8%)/12 (25.5%)
|
73 (68.2%)/35 (74.5%)
|
0.608/1/0.44
|
|
BMI (kg/m2)
|
25.3 ± 3.7
|
25.4 ± 3.2
|
-0.176/145/0.86
|
|
Waist (cm)
|
93.5 ± 11.7
|
91.6 ± 10.9
|
0.936/151/0.35
|
|
SBP (mmHg)
|
143 ± 21
|
147 ± 16
|
-1.169/152/0.24
|
|
DBP (mmHg)
|
82 ± 10
|
81 ± 9
|
1.069/152/0.29
|
|
Concomitant disorders, n (%)
|
|
Hypertension
|
38 (82.6%)
|
83 (76.9%)
|
0.635/1/0.43
|
|
MI
|
6 (13.0%)
|
11 (10.2%)
|
0.268/1/0.60
|
|
HF
|
7 (15.2)*
|
0 (0.0%)
|
< 0.001 (Fisher)
|
|
Valve surgery
|
3 (6.5%)*
|
1 (0.9%)
|
0.046 (Fisher)
|
|
CABG/PCI
|
6 (13.0%)
|
8 (7.4%)
|
1.240/1/0.27
|
|
Cerebrovascular disease
|
5 (10.9%)*
|
2 (1.9%)
|
0.025 (Fisher)
|
|
Medication, n (%)
|
|
Warfarin
|
33 (76.1%)*
|
4 (3.7%)
|
< 0.001 (Fisher)
|
|
Acetylic acid
|
3 (6.5%)
|
33 (30.6%)*
|
0.001 (Fisher)
|
|
Digitoxin
|
8 (17.4)*
|
0 (0%)
|
< 0.001 (Fisher)
|
|
Verapamil
|
10 (21.7)*
|
2 (1.9)
|
< 0.001 (Fisher)
|
|
Other Ca2+ blockers
|
4 (8.7)
|
11 (8.7)
|
1.000 (Fisher)
|
|
Beta blockers
|
14 (30.4%)*
|
16 (14.8%)
|
5.018/1/0.03*
|
|
ACE inhibitor
|
12 (26.1%)*
|
13 (12.0%)
|
4.683/1/0.03*
|
|
AT-II antagonist
|
13 (28.3%)*
|
13 (12.0%)
|
6.051/1/0.01*
|
|
Diuretics
|
12 (26.1%)*
|
5 (4.6%)
|
15.125/1/<0.001*
|
|
Statins
|
18 (39.1)*
|
19 (17.6)
|
8.198/1/0.01*
|
|
Laboratory parameters
|
|
Total leukocyte count (109)
|
6.0 ± 1.3
|
6.2 ± 1.6
|
-0.52/140/0.61
|
|
Creatinine (μmol/l)
|
84 ± 21
|
80 ± 23
|
0.93/137/0.35
|
|
Total cholesterol (mmol/l)
|
5.2 ± 1.0*
|
5.6 ± 1.1
|
-2.326/140/0.02*
|
|
Triglycerides (mmol/l)
|
1.1 ± 0.8
|
1.1 ± 0.6
|
0.162/140/0.87
|
|
HDL-cholesterol (mmol/l)
|
1.7 ± 0.6
|
1.7 ± 0.5
|
0.443/140/0.66
|
|
LDL-cholesterol (mmol/l)
|
2.9 ± 0.9*
|
3.4 ± 1.0
|
-2.713/139/0.01
|
- *: p ≤ 0.05. Abbreviations: BMI – body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, MI – myocardial infarction, HF – heart failure, CABG – coronary artery by-pass graft, PCI – percutaneous coronary intervention, Ca2+-calcium, ACE – angiotensin converting enzyme, AT-II – angiotensin II, HDL – high density lipoprotein, LDL – low density lipoprotein.
